Cargando…
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3(rd)-line treatment
BACKGROUND: Somatostatin analogues are an established first-line therapy for well differentiated small bowel neuroendocrine tumours (Wd-SBNETs), while and peptide receptor radionuclide therapy (PRRT) is frequently used as a second-line therapy. Adequate treatment selection of third-line treatment re...
Autores principales: | Lamarca, Angela, Cives, Mauro, de Mestier, Louis, Crona, Joakim, Spada, Francesca, Öberg, Kjell, Pavel, Marianne, Alonso-Gordoa, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968134/ https://www.ncbi.nlm.nih.gov/pubmed/33776367 http://dx.doi.org/10.3748/wjg.v27.i10.976 |
Ejemplares similares
-
The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
por: Cives, Mauro, et al.
Publicado: (2022) -
1110P COVID-19 pandemic impact on healthcare professionals treating patients with neuroendocrine tumors (NET): An international NET CONNECT survey
por: Hernando, J., et al.
Publicado: (2021) -
Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma
por: Mollazadegan, Kazhan, et al.
Publicado: (2021) -
Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020) -
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
por: Dromain, Clarisse, et al.
Publicado: (2021)